Rosiglitazone Protects Endothelial Cells From Irradiation-Induced Mitochondrial Dysfunction

BACKGROUND AND PURPOSE: Up to 50–60% of all cancer patients receive radiotherapy as part of their treatment strategy. However, the mechanisms accounting for increased vascular risks after irradiation are not completely understood. Mitochondrial dysfunction has been identified as a potential cause of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Baselet, Bjorn, Driesen, Ronald B., Coninx, Emma, Belmans, Niels, Sieprath, Tom, Lambrichts, Ivo, De Vos, Winnok H., Baatout, Sarah, Sonveaux, Pierre, Aerts, An
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7082323/
https://ncbi.nlm.nih.gov/pubmed/32231569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00268
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados